Title: Associate Professor
Company: Iowa State University
Location: Ames, Iowa, United States
Jonathan P. Mochel, Associate Professor at Iowa State University, has been recognized by Marquis Who’s Who Top Educators for dedication, achievements, and leadership in pharmacological research.
In 2006, Dr. Mochel obtained a Veterinary Medicine Degree from the National Veterinary School of Toulouse in France, as well as a Master of Science in pharmacology from the Paul Sabatier University in France. The following year, he earned a doctorate in veterinary medicine from Alfort Veterinary School in Paris, with the highest honorable mention. He followed with a Master of Science in clinical pharmacology and pharmacokinetics from Paul Sabatier University in 2009 and after serving a residency in veterinary pharmacology and toxicology with the European College of Veterinary Pharmacology and Toxicology in Basel, Switzerland from 2009 to 2013, he continued his education with a Doctor of Philosophy in quantitative systems pharmacology from Leiden University in the Netherlands in 2015.
Dr. Mochel prospered for four years with Novartis as a senior pharmacology modeler from 2011 to 2015, during which time he developed and executed model-based analysis plans for the quantitative evaluation of competing trial/analysis strategies to support clinical development of new drug candidates, a role with which he continued with Roche in Basel from 2015 to 2016. As an entrepreneur, Dr. Mochel co-founded LEAH Laboratories in 2018, whose technology enables precision gene editing for treatment of lymphoma, which accounts for 83 percent of all canine blood cell malignancies; and 3-D Health Solutions in 2019, a start-up entity that is seeking to expand upon and commercialize 3-dimensional in vitro canine cell culture lines for therapeutic drug screening purposes.
Dr. Mochel has also flourished in academia. From 2013 to the present, he has served as European veterinary specialist in pharmacology and toxicology and chair of the Education and Residency Committee with the European College of Veterinary Pharmacology and Toxicology. In addition, since 2016 he has excelled as an associate professor with the Department of Biomedical Sciences at Iowa State University College of Veterinary Medicine, where his research pertains to the analysis of clinical data obtained from spontaneous animal models of human diseases to bridge the knowledge gap between experimental models and patients.
Dr. Moche’s numerous honors include the IowaBio Biotechnology Association Award, Iowa State University CVM International Service Award, Iowa State Exemplary Faculty Mentor Award, John Pappajohn Entrepreneurial Venture Competition Award, Iowa State CVM (College of Veterinary Medicine) Award for Early Career Achievement in Research and Valedictorian, Master of Sciences (M2), Paul Sabatier University.
Dr. Mochel summarizes the reason for his success has been constructing a wide network of collaborators across the United States, as well as in Europe. His immediate environment, specifically his family, has been the backbone of his achievements. Their loving support helped nurture and accelerate his professional growth. He is particularly proud to have been prolific, publishing more than 90 learned papers as well as being responsible, along with the Mayo Clinic, for the first National Institutes of Health (NIH)-sponsored research on dogs at the college in the history of Iowa State University. In the near future, he is looking forward to becoming a full-time professor at Iowa State University College of Veterinary Medicine. In 2022, he is slated to become the next president for the Veterinary Pharmacology and Therapeutics Associations in Europe. He wants to be change the landscape of animal health field by helping to introduce new methods, including artificial intelligence, to optimize research in the area.
For more information, please visit:
Contact Dr. Mochel:
